Extraordinary general meeting

Kitchen Culture Criticises Requisitioners for 'Diametrically Changing' Minds by Publishing Advertisement to Call off EGM to Remove 5 Directors; Company Affirms 1 November EGM Will Not Proceed

Retrieved on: 
Monday, October 31, 2022
Publishing, Annual, EGM, Company, Board, Executive, AIA Tower, Confusion, Lawyer, Advertising, TEL, Singapore, Solution, Interim, ACN, Annual general meeting, S.A.C. Capital Advisors, SGX, The Sunday Times, Extraordinary general meeting, Frustration, Sponsor, News, Public relations, Management

The Company said that some shareholders may not be aware of the latest advertisement by the requisitioners whose conduct has continued to cause confusion.

Key Points: 
  • The Company said that some shareholders may not be aware of the latest advertisement by the requisitioners whose conduct has continued to cause confusion.
  • Kitchen Culture has been receiving calls from shareholders expressing confusion and frustration as they had not received the Purported Notices and proxy forms in the days leading up to the EGM.
  • Kitchen Culture has said that 2 law firms have advised that Purported Notices were defective and that any resolutions passed on 1 November 2022 would be invalid.
  • The Company will write to the requisitioners for clarifications and confirmations on this and other relevant points, as appropriate.

Meyer Burger Technology AG: Start of Subscription Period and Rights Trading

Retrieved on: 
Monday, October 31, 2022
Exercise, Board, SIX Swiss Exchange, Extraordinary general meeting, Meyer Burger, CET, CHF, Director, Security (finance)

Holders of 20 subscription rights are entitled to purchase 7 new shares at a price of CHF 0.267 per new share.

Key Points: 
  • Holders of 20 subscription rights are entitled to purchase 7 new shares at a price of CHF 0.267 per new share.
  • Trading of subscription rights at the SIX Swiss Exchange starts on November 1, 2022 and ends on November 7, 2022.
  • Meyer Burger shareholders are expected to receive one subscription right for each registered share they hold as of October 31, 2022 (after close of trading).
  • The subscription rights will be transferable and tradable via the envisaged rights trading on SIX Swiss Exchange.

EQS-News: EBM decides on a rights issue of approx. SEK 49.6M and proposes an authorisation for an over-allotment issue of an additional approx. SEK 15M and decides on the issue of a convertible loan of SEK 10M

Retrieved on: 
Monday, October 31, 2022
Board, Securities Act of 1933, Board of directors, British Virgin Islands company law, Association, Mineral, Rights issue, Bird, Acquisition, Mining, A/S, Nickel, OR, Rights, News, TERP, EBM, AFRICA, CEO, PFS, Prospectus, Director, Exercise, BE, Convertible, Copper, THIS, Cobalt, BAT, SEK, Extraordinary general meeting, Company, PEA, Person, Poultry, Security (finance), Animal, Television, Renewable energy, Sugar, Life insurance, Cryptocurrency, EU, NEW ZEALAND, Ford Corcel, Nordic Growth Market

SEK 15M and decides on the issue of a convertible loan of SEK 10M

Key Points: 
  • SEK 15M and decides on the issue of a convertible loan of SEK 10M
    The issuer is solely responsible for the content of this announcement.
  • The Rights issue is secured to approximately SEK 24.8 million, corresponding to 50.0 per cent of the Rights issue, by subscription and underwriting commitments.
  • The subscription price in the Rights issue is SEK 3.00 per unit, corresponding to SEK 3.00 per share (the warrants are obtained free of charge).
  • For each (1) existing share held on the record date, one (1) unit right is obtained in the Rights issue.

Meyer Burger’s shareholders approve the ordinary capital increase with a large majority and support the path of accelerated growth for the company

Retrieved on: 
Friday, October 28, 2022
Director, SIX Swiss Exchange, Board, CHF, Extraordinary general meeting, Board of directors, Trust, General officer, CET, Exercise, Meyer Burger, Growth, Security (finance)

At the Extraordinary General Meeting, a total of 1,111,844,450 shares (41.63 percent of the shares issued) were represented by 302 shareholders on site.

Key Points: 
  • At the Extraordinary General Meeting, a total of 1,111,844,450 shares (41.63 percent of the shares issued) were represented by 302 shareholders on site.
  • Chairman of the Board of Directors Franz Richter on the decision of the General Meeting: We would like to thank all shareholders for their trust and for supporting our growth strategy.
  • The capital increase shall take the form of a rights offering to existing shareholders.
  • Meyer Burger shareholders will receive one subscription right for each registered share they hold as of October 31, 2022 (after close of trading).

Mereo BioPharma Reaches Cooperation Agreement with Rubric Capital Management

Retrieved on: 
Friday, October 28, 2022
Therapy, Company, Extraordinary general meeting, NASDAQ, Motion, OI, Osteogenesis imperfecta, Respiratory tract, Patient, Board, Partner, LONDON, Resolution, GLOBE, AATD, Mass meeting, Degenerative disease, Shareholder, BOS, Agreement, Rubric

LONDON, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced it has entered into a cooperation agreement (the “Agreement”) with Rubric Capital Management LP (“Rubric”), its largest shareholder. Pursuant to the Agreement, four new directors – Dr. Annalisa Jenkins, Dr. Daniel Shames, Mr. Marc Yoskowitz and Mr. Justin Roberts – will be appointed to the Company’s Board of Directors as soon as practicable. Concurrent with these appointments taking effect, directors Dr. Peter Fellner, Dr. Brian Schwartz, Dr. Abdul Mullick and Ms. Anne Hyland will resign from the Board.

Key Points: 
  • Rubric has Withdrawn its General Meeting Requisition Notice and Related Proposals; Agrees to Standstill Provision Through Mereos 2024 Annual General Meeting of Shareholders
    LONDON, Oct. 28, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (Mereo or the Company), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced it has entered into a cooperation agreement (the Agreement) with Rubric Capital Management LP (Rubric), its largest shareholder.
  • Rubric has withdrawn its notice dated October 3, 2022 (the Requisition Notice) which required Mereo to call a General Meeting of its shareholders (the General Meeting).
  • Rubric invested in Mereo because we believe in the Companys mission and the inherent potential of its promising programs.
  • Our Agreement reflects our confidence in that potential and our shared goal to maximize impact and value for all shareholders, said David Rosen, Founder and Partner of Rubric Capital Management.

Mereo BioPharma Files Shareholder Circular for Upcoming General Meeting

Retrieved on: 
Friday, October 21, 2022
Proxy, Mass meeting, Osteogenesis imperfecta, Expense, Therapy, Quality, ADS, W postcode area, Link group, NASDAQ, THE, Biotechnology, Patient, General officer, CREST, Extraordinary general meeting, Program, Company, Partnership, Degenerative disease, BOS, Shareholder, Industry, Board, Respiratory tract, GLOBE, Environment, OI, Composition, Disclosure, ALL, AATD, Circular, Leadership, Management, Auction, Holding company, Security (finance), Risk management, Rubric

LONDON, Oct. 21, 2022 (GLOBE NEWSWIRE) -- Mereo BioPharma Group plc (NASDAQ: MREO), (“Mereo” or the “Company”), a clinical-stage biopharmaceutical company focused on rare diseases and oncology, today announced it has filed and mailed a shareholder circular (the “Shareholder Circular”) and related meeting and proxy materials in connection with its upcoming General Meeting of Shareholders (the “General Meeting”) to be held on November 18, 2022 at 2:00 p.m. London time.

Key Points: 
  • At the General Meeting, shareholders will consider resolutions to remove five of Mereos directors and replace them with five directors nominated by Rubric.
  • Mereo recommends that shareholders vote and vote against all of the resolutions to be put to the General Meeting.
  • Mereo also today issued the following notice to shareholders, which will accompany the physical mailing of the Shareholder Circular.
  • The Shareholder Circular contains, among other information, details regarding procedures for voting at the General Meeting, as well as comprehensive information regarding Mereos engagement with Rubric and perspectives on its resolutions.

Energem Corp. Announces Filing of Definitive Extension Proxy Statement and Reminds Stockholders to Vote in Favor of Extension Amendment Ahead of Extraordinary General Meeting

Retrieved on: 
Tuesday, October 18, 2022
Transfer, U.S. Securities and Exchange Commission, Time, Sale, Telephone, SEC, Common stock, Person, Annual report, Security (finance), Securities Act of 1933, Nasdaq, Company, Extraordinary general meeting, Acquisition, Association, Bank account, Proxy, GLOBE, Trust, Prospectus, Forward-looking statement, Continental, Shareholder, Extension, Interest on Lawyer Trust Accounts, Name, Internet service provider

The Extraordinary General Meeting to approve the Extension Amendment will be held virtually at 9:00 a.m. Eastern Time on November 11, 2022 and can be accessed by visiting https://www.cstproxy.com/energemcorp/2022 .

Key Points: 
  • The Extraordinary General Meeting to approve the Extension Amendment will be held virtually at 9:00 a.m. Eastern Time on November 11, 2022 and can be accessed by visiting https://www.cstproxy.com/energemcorp/2022 .
  • The Company encourages its shareholders to vote in favor of the Extension Amendment and the Trust Amendment.
  • Every shareholders vote is very important, regardless of the number of shares held, and the Company requests the prompt submission of votes.
  • Shareholders will not be able to vote or submit questions unless they register for and log in to the Extraordinary General Meeting webcast.

3D Releases Investor Presentation in Support of Its EGM Resolutions to Appoint Four New Outside Directors at Fuji soft Incorporated

Retrieved on: 
Thursday, October 13, 2022
Hardware, Professional Services, Other Professional Services, Technology, Software, News, International trade, Sale, Financial Instruments and Exchange Act, Growth, Person, Extraordinary general meeting, 3D, Investment, Philosophy, Company, Exercise, Financial instrument, Board, Intention, Third party, Board of directors, Foreign exchange market, Language, Management, Heavy industry, Public relations, Director

Ltd. as investment manager of 3D OPPORTUNITY MASTER FUND (together 3D) today published a presentation regarding its shareholder proposals to enhance board composition at Fuji soft Incorporated (Fuji soft or the Company) (9749.T).

Key Points: 
  • Ltd. as investment manager of 3D OPPORTUNITY MASTER FUND (together 3D) today published a presentation regarding its shareholder proposals to enhance board composition at Fuji soft Incorporated (Fuji soft or the Company) (9749.T).
  • 3D has nominated four candidates to be added to the Fuji soft Board of Directors.
  • The presentation is available at:
    3D currently owns more than 21% of Fuji soft and is the Companys largest shareholder.
  • 3Ds proposal seeks to appoint four such directors, all of whom are completely independent of 3D and Fuji soft.

VectivBio Announces Date of Extraordinary General Meeting of Shareholders

Retrieved on: 
Wednesday, October 12, 2022
U.S. Securities and Exchange Commission, MMA, SBS, Short bowel syndrome, Coenzyme A, Pantetheine, Patient, Manufacturing execution system, Degenerative disease, Security (finance), Coronavirus, Nasdaq, Extraordinary general meeting, Exercise, Board, Community of Metros, Propionic acidemia, CEST, Congenital disorders of amino acid metabolism, EDT, Phrase, GLOBE, Proxy, Director, Forward-looking statement, Respiration (physiology), Federal Council (Switzerland), COVID-19, Holding company, Pharmaceutical industry

The sole agenda item of the Extraordinary General Meeting will be the election of Wouter Joustra as a new member of the Board of Directors.

Key Points: 
  • The sole agenda item of the Extraordinary General Meeting will be the election of Wouter Joustra as a new member of the Board of Directors.
  • Shareholders shall be represented at the Extraordinary General Meeting exclusively by the independent proxy.
  • For information on how to exercise rights and issue voting instructions to the independent proxy, shareholders can access the invitation to the Extraordinary General Meeting at www.edocumentview.com/VECT .
  • These statements include, but are not limited to, statements concerning the timing of the Extraordinary General Meeting.

Invitation to Extraordinary General Meeting 2022

Retrieved on: 
Tuesday, October 11, 2022
Remuneration, Mass meeting, Audit committee, Annual, Person, General officer, Annual general meeting, Board of directors, Spotlight Group, Extraordinary general meeting, Exercise, Group, Board, CEO, Nordnet, Proxy, BankID, Director, Master, PostNord Sverige, Chairperson, SEK, RaySearch Laboratories, Euroclear, Holding company, Security (finance), Management, Health insurance, Audit, Economics

STOCKHOLM, Oct. 11, 2022 /PRNewswire/ -- The Board of Directors has decided that the General Meeting is to be held only through postal voting in accordance with temporary legislation applicable since March 1, 2022. This means that the General Meeting will be conducted without the physical presence of shareholders, representatives or external parties. Shareholders will only be able to exercise their voting rights by postal voting in advance of the General Meeting in the manner described below.

Key Points: 
  • 556322-6157, are hereby invited to the Extraordinary General Meeting, to be held on Wednesday, November 9, 2022.
  • STOCKHOLM, Oct. 11, 2022 /PRNewswire/ --The Board of Directors has decided that the General Meeting is to be held only through postal voting in accordance with temporary legislation applicable since March 1, 2022.
  • The completed and signed form must be sent by mail to RaySearch Laboratories AB (publ), "Extraordinary General Meeting 2022", c/o Euroclear Sweden AB, Box 191, SE-101 23 Stockholm, Sweden or by e-mail to [email protected] .
  • Otherwise, remuneration for the members of the Board elected at the Annual General Meeting 2022, including any remuneration for work in Board Committees, shall remain unchanged according to the resolution by the Annual General Meeting 2022, as applicable in proportion to the duration of the term of office.